BRK-B vs GSBC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GSBC exhibits a stable financial profile with a Piotroski F-Score of 4/9, placing it in the 'Stable' health category. The stock is fundamentally undervalued, trading at $67.77, which is significantly below both its Graham Number ($89.49) and its growth-based Intrinsic Value ($182.61). However, this value is offset by stagnant revenue growth (1.00% YoY) and a strongly bearish insider sentiment with $1.28M in recent sales. While the company has a stellar track record of earnings beats, the current technical trend and insider activity suggest a lack of immediate catalyst for a breakout.
Compare Another Pair
Related Comparisons
BRK-B vs GSBC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Great Southern Bancorp, Inc. (GSBC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.